Cargando…

Comparison of the tumor immune microenvironment phenotypes in different breast cancers after neoadjuvant therapy

Neoadjuvant therapy (NAT) treats early‐stage breast cancers, especially triple‐negative breast cancers (TNBCs). NAT improves pathological complete response (pCR) rates for different breast cancer patients. Recently, immune checkpoint inhibitors that target programmed death 1 (PD‐1) or programmed dea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Mengxue, Li, Jinze, Wu, Si, Wu, Chun, Yu, Yongqiang, Liu, Yueping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939127/ https://www.ncbi.nlm.nih.gov/pubmed/36073303 http://dx.doi.org/10.1002/cam4.5207

Ejemplares similares

Development and Validation of a Novel Model for Predicting Prognosis of Non-PCR Patients After Neoadjuvant Therapy for Breast Cancer
por: Yu, Yongqiang, et al.
Publicado: (2021)

Reconstructing virtual large slides can improve the accuracy and consistency of tumor bed evaluation for breast cancer after neoadjuvant therapy
por: Han, Dandan, et al.
Publicado: (2022)

Artificial intelligence-assisted interpretation of Ki-67 expression and repeatability in breast cancer
por: Li, Lina, et al.
Publicado: (2022)

Neoadjuvant therapy alters the immune microenvironment in pancreatic cancer
por: Zhang, Huiru, et al.
Publicado: (2022)

The breast cancer immune microenvironment is modified by neoadjuvant chemotherapy
por: Urueña, Claudia, et al.
Publicado: (2022)

The effect of neoadjuvant chemotherapy on the tumor immune microenvironment in gastrointestinal tumors
por: Wang, Yujie, et al.
Publicado: (2022)

Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic and Neoadjuvant Chemotherapy Relevant Signatures
por: Ji, Fei, et al.
Publicado: (2021)

Cellular heterogeneity map of diverse immune and stromal phenotypes within breast tumor microenvironment
por: Li, Yuan, et al.
Publicado: (2020)

Integrated tumor genomic and immune microenvironment analysis identifies predictive biomarkers associated with the efficacy of neoadjuvant therapy for triple‐negative breast cancer
por: Zhu, Yanhui, et al.
Publicado: (2022)

Evolution and clinical significance of HER2-low status after neoadjuvant therapy for breast cancer
por: Shang, Jiuyan, et al.
Publicado: (2023)

Differences in Tumor Immune Microenvironment in Metastatic Sites of Breast Cancer
por: Lee, Hyunjong, et al.
Publicado: (2021)

Radiomics Assessment of the Tumor Immune Microenvironment to Predict Outcomes in Breast Cancer
por: Han, Xiaorui, et al.
Publicado: (2022)

Genomic features and tumor immune microenvironment alteration in NSCLC treated with neoadjuvant PD-1 blockade
por: Wang, Shuhang, et al.
Publicado: (2022)

Predicting cell invasion in breast tumor microenvironment from radiological imaging phenotypes
por: Arefan, Dooman, et al.
Publicado: (2021)

Assisted computer and imaging system improve accuracy of breast tumor size assessment after neoadjuvant chemotherapy
por: Zhang, Meng, et al.
Publicado: (2021)

The immune microenvironment characterisation and dynamics in hormone receptor–positive breast cancer before and after neoadjuvant endocrine therapy
por: Oner, Gizem, et al.
Publicado: (2023)

Tumor immune microenvironment predicts the pathologic response of neoadjuvant chemoimmunotherapy in non–small‐cell lung cancer
por: Han, Rui, et al.
Publicado: (2023)

Predictive value of improvement in the immune tumour microenvironment in patients with breast cancer treated with neoadjuvant chemotherapy
por: Goto, Wataru, et al.
Publicado: (2018)

Identification of Ferroptosis-Related Prognostic Signature and Subtypes Related to the Immune Microenvironment for Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Xu, Yuhao, et al.
Publicado: (2022)

Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab
por: Tarhini, Ahmad A., et al.
Publicado: (2014)

Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer
por: Lee, Yong Jae, et al.
Publicado: (2022)

CpG Island Methylator Phenotype Modulates the Immune Response of the Tumor Microenvironment and Influences the Prognosis of Pancreatic Cancer Patients
por: Ning, Gang, et al.
Publicado: (2021)

Racial disparity in tumor microenvironment and distant recurrence in residual breast cancer after neoadjuvant chemotherapy
por: Kim, Gina, et al.
Publicado: (2023)

Comparison of immune microenvironments between primary tumors and brain metastases in patients with breast cancer
por: Ogiya, Rin, et al.
Publicado: (2017)

Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma
por: Gartrell, Robyn D., et al.
Publicado: (2022)

Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer
por: Abdul Sater, Houssein, et al.
Publicado: (2020)

Characterization of the immune microenvironment in brain metastases from different solid tumors
por: Jiang, Jinling, et al.
Publicado: (2020)

Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma
por: Deng, Chuangzhong, et al.
Publicado: (2020)

Immune microenvironment changes induced by neoadjuvant chemotherapy in triple-negative breast cancers: the MIMOSA-1 study
por: Sarradin, Victor, et al.
Publicado: (2021)

Integrating Genomic Information with Tumor-Immune Microenvironment in Triple-Negative Breast Cancer
por: Otohinoyi, David, et al.
Publicado: (2022)

Tumor Microenvironment Subtypes and Immune-Related Signatures for the Prognosis of Breast Cancer
por: Han, Yiqun, et al.
Publicado: (2021)

Multiomics technologies for comprehensive tumor microenvironment analysis in triple-negative breast cancer under neoadjuvant chemotherapy
por: Wang, Gang, et al.
Publicado: (2023)

The immune microenvironment after neoadjuvant therapy compared to upfront surgery in patients with pancreatic cancer
por: Zwart, Eline S., et al.
Publicado: (2023)

Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of oesophagael adenocarcinoma
por: Barroux, Melissa, et al.
Publicado: (2023)

Cryoablation reshapes the immune microenvironment in the distal tumor and enhances the anti-tumor immunity
por: Wu, Ying, et al.
Publicado: (2022)

The Research Progress of Antiangiogenic Therapy, Immune Therapy and Tumor Microenvironment
por: Hu, Haoyue, et al.
Publicado: (2022)

Determination of BRCAness Phenotype in Breast Tumors for the Appointment of Neoadjuvant Chemotherapy Based on Platinum and Taxanes
por: Tsyganov, Matvey Mihajlovich, et al.
Publicado: (2022)

A tumor microenvironment-related risk model for predicting the prognosis and tumor immunity of breast cancer patients
por: Geng, Shengkai, et al.
Publicado: (2022)

Tumor immune microenvironment lncRNAs
por: Park, Eun-Gyeong, et al.
Publicado: (2021)

Immune Microenvironment in Tumor Progression: Characteristics and Challenges for Therapy
por: Chew, Valerie, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vn844ld3ost9pngavlgpriar3o